Hollsteen
← Texas Instruments

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 2016: $1.3B · 10-Q 0001564590-16-017570 filed May 4, 2016Cash and equivalents · Q2 2016: $1.2B · 10-Q 0001564590-16-022552 filed Aug 4, 2016Cash and equivalents · Q3 2016: $1.4B · 10-Q 0001564590-16-027067 filed Nov 3, 2016Cash and equivalents · Q4 2016: $1.2B · 10-K 0001564590-17-002142 filed Feb 23, 2017Cash and equivalents · Q1 2017: $1.1B · 10-Q 0001564590-17-008260 filed May 3, 2017Cash and equivalents · Q2 2017: $1.1B · 10-Q 0001564590-17-015153 filed Aug 3, 2017Cash and equivalents · Q3 2017: $1.3B · 10-Q 0001564590-17-021032 filed Nov 2, 2017Cash and equivalents · Q4 2017: $1.7B · 10-K 0001564590-18-002832 filed Feb 22, 2018Cash and equivalents · Q1 2018: $1.7B · 10-Q 0001564590-18-010545 filed May 3, 2018Cash and equivalents · Q2 2018: $2.9B · 10-Q 0001564590-18-018753 filed Aug 2, 2018Cash and equivalents · Q3 2018: $1.5B · 10-Q 0001564590-18-026405 filed Nov 2, 2018Cash and equivalents · Q4 2018: $2.4B · 10-K 0001564590-19-003839 filed Feb 22, 2019Cash and equivalents · Q1 2019: $3.7B · 10-Q 0001564590-19-014051 filed Apr 30, 2019Cash and equivalents · Q2 2019: $3.8B · 10-Q 0001564590-19-027328 filed Jul 31, 2019Cash and equivalents · Q3 2019: $3.9B · 10-Q 0000097476-19-000009 filed Oct 31, 2019Cash and equivalents · Q4 2019: $2.4B · 10-K 0000097476-20-000009 filed Feb 20, 2020Cash and equivalents · Q1 2020: $2.5B · 10-Q 0000097476-20-000017 filed Apr 22, 2020Cash and equivalents · Q2 2020: $4.3B · 10-Q 0000097476-20-000026 filed Jul 22, 2020Cash and equivalents · Q3 2020: $2.8B · 10-Q 0001628280-20-014630 filed Oct 21, 2020Cash and equivalents · Q4 2020: $3.1B · 10-K 0000097476-21-000006 filed Feb 5, 2021Cash and equivalents · Q1 2021: $2.4B · 10-Q 0000097476-21-000013 filed Apr 28, 2021Cash and equivalents · Q2 2021: $3.6B · 10-Q 0000097476-21-000020 filed Jul 22, 2021Cash and equivalents · Q3 2021: $5.7B · 10-Q 0000097476-21-000032 filed Oct 27, 2021Cash and equivalents · Q4 2021: $4.6B · 10-K 0000097476-22-000009 filed Feb 4, 2022Cash and equivalents · Q1 2022: $3.5B · 10-Q 0000097476-22-000028 filed Apr 27, 2022Cash and equivalents · Q2 2022: $3.8B · 10-Q 0000097476-22-000040 filed Jul 27, 2022Cash and equivalents · Q3 2022: $3.2B · 10-Q 0000097476-22-000048 filed Oct 26, 2022Cash and equivalents · Q4 2022: $3.0B · 10-K 0000097476-23-000007 filed Feb 3, 2023Cash and equivalents · Q1 2023: $4.5B · 10-Q 0000097476-23-000025 filed Apr 26, 2023Cash and equivalents · Q2 2023: $3.4B · 10-Q 0000097476-23-000035 filed Jul 26, 2023Cash and equivalents · Q3 2023: $2.6B · 10-Q 0000097476-23-000041 filed Oct 25, 2023Cash and equivalents · Q4 2023: $3.0B · 10-K 0000097476-24-000007 filed Feb 2, 2024Cash and equivalents · Q1 2024: $2.5B · 10-Q 0000097476-24-000021 filed Apr 24, 2024Cash and equivalents · Q2 2024: $2.7B · 10-Q 0000097476-24-000030 filed Jul 24, 2024Cash and equivalents · Q3 2024: $2.6B · 10-Q 0000097476-24-000042 filed Oct 23, 2024Cash and equivalents · Q4 2024: $3.2B · 10-K 0000097476-25-000007 filed Feb 14, 2025Cash and equivalents · Q1 2025: $2.8B · 10-Q 0000097476-25-000027 filed Apr 24, 2025Cash and equivalents · Q2 2025: $3.0B · 10-Q 0000097476-25-000036 filed Jul 29, 2025Cash and equivalents · Q3 2025: $3.3B · 10-Q 0000097476-25-000060 filed Oct 23, 2025Cash and equivalents · Q4 2025: $3.2B · 10-K 0000097476-26-000059 filed Feb 6, 2026Cash and equivalents · Q1 2026: $3.5B · 10-Q 0000097476-26-000101 filed Apr 24, 2026Cash and equivalents · Q2 2026: $3.7B · 10-Q 0000097476-26-000152 filed Jul 24, 20265,6633,6601,281Q1 2016Q2 2026Q3 2021
$MCash and equivalents · Q3 2020: $2.8B · 10-Q 0001628280-20-014630 filed Oct 21, 2020Cash and equivalents · Q4 2020: $3.1B · 10-K 0000097476-21-000006 filed Feb 5, 2021Cash and equivalents · Q1 2021: $2.4B · 10-Q 0000097476-21-000013 filed Apr 28, 2021Cash and equivalents · Q2 2021: $3.6B · 10-Q 0000097476-21-000020 filed Jul 22, 2021Cash and equivalents · Q3 2021: $5.7B · 10-Q 0000097476-21-000032 filed Oct 27, 2021Cash and equivalents · Q4 2021: $4.6B · 10-K 0000097476-22-000009 filed Feb 4, 2022Cash and equivalents · Q1 2022: $3.5B · 10-Q 0000097476-22-000028 filed Apr 27, 2022Cash and equivalents · Q2 2022: $3.8B · 10-Q 0000097476-22-000040 filed Jul 27, 20225,6633,8022,822Q3 2020Q2 2022Q3 2021
Q3 2021
5,663$M
All values (42)
PeriodValue ($M)Status
Q2 20263,660reported
Q1 20263,549reported
Q4 20253,225reported
Q3 20253,311reported
Q2 20253,044reported
Q1 20252,763reported
Q4 20243,200reported
Q3 20242,589reported
Q2 20242,740reported
Q1 20242,483reported
Q4 20232,964reported
Q3 20232,566reported
Q2 20233,439reported
Q1 20234,477reported
Q4 20223,050reported
Q3 20223,169reported
Q2 20223,802reported
Q1 20223,505reported
Q4 20214,631reported
Q3 20215,663reported
Q2 20213,649reported
Q1 20212,442reported
Q4 20203,107reported
Q3 20202,822reported
Q2 20204,294reported
Q1 20202,518reported
Q4 20192,437reported
Q3 20193,893reported
Q2 20193,813reported
Q1 20193,720reported
Q4 20182,438reported
Q3 20181,502reported
Q2 20182,919reported
Q1 20181,717reported
Q4 20171,656reported
Q3 20171,296reported
Q2 20171,140reported
Q1 20171,073reported
Q4 20161,154reported
Q3 20161,369reported
Q2 20161,235reported
Q1 20161,281reported

CSV with all sources · Technical ID: cash

More metrics for Texas Instruments

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Gross profit by segment

Sources & calculation
Value
$5.7B
Period
Q3 2021, ended Sep 30, 2021 · as of Sep 30, 2021 (balance as of date, not a sum)
Source
10-Q, filed Oct 27, 2021 · 0000097476-21-000032
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$5.7BOct 27, 202110-Q 0000097476-21-000032reported · confidence 1. · current